Bavarian Nordic A/S (BVNRY)
OTCMKTS · Delayed Price · Currency is USD
10.13
-0.06 (-0.59%)
At close: Feb 6, 2026
Bavarian Nordic Market Cap
Bavarian Nordic has a market cap or net worth of $2.38 billion as of February 9, 2026. Its market cap has increased by 8.99% in one year.
Market Cap
2.38B
Enterprise Value
1.93B
Revenue
1.08B
Ranking
n/a
PE Ratio
6.18
Stock Price
$10.13
Market Cap Chart
Since November 5, 1998, Bavarian Nordic's market cap has increased from 6.78M to 2.38B, an increase of 34,913.86%. That is a compound annual growth rate of 23.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 2.38B | 0.95% |
| Dec 30, 2025 | 2.35B | 13.64% |
| Dec 30, 2024 | 2.07B | 0.95% |
| Dec 29, 2023 | 2.05B | -5.24% |
| Dec 30, 2022 | 2.16B | -24.82% |
| Dec 30, 2021 | 2.88B | 59.81% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 406.62M |
| CytoDyn | 317.38M |
| Silence Therapeutics | 224.36M |
| Vaxart | 145.67M |
| HST Global | 139.70M |
| BioStem Technologies | 104.83M |
| Nuo Therapeutics | 80.63M |
| VitaSpring Biomedical | 51.78M |